<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-3d61-56a7-013e-65c9c3043e54</uuid><title>Use of High-Risk Medications in the Elderly</title><shortTitle>High-Risk_Med_Elderly</shortTitle><emeasureid>156</emeasureid><guid>a3837ff8-1abc-4ba9-800e-fd4e7953adbd</guid><version>2</version><status>Complete</status><nqfid extension="0022" root="2.16.840.1.113883.3.560.1"/><period uuid="d6ff5925-bfa1-40a3-be67-9428e7786fe9"><startDate uuid="a4abda1d-f93d-449a-89b7-7c59927c6a09">00000101</startDate><stopDate uuid="93ab69c1-2230-4b11-bc74-ceaac6e1bd07">00001231</stopDate></period><steward id="2.16.840.1.113883.3.464">National Committee for Quality Assurance</steward><developers><developer id="2.16.840.1.113883.3.464">National Committee for Quality Assurance</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>Percentage of patients 66 years of age and older who were ordered high-risk medications. Two rates are reported.
a. Percentage of patients who were ordered at least one high-risk medication. 
b. Percentage of patients who were ordered at least two different high-risk medications.</description><copyright>Physician Performance Measure (Measures) and related data specifications were developed by the National Committee for Quality Assurance (NCQA). 

The Measures are copyrighted but can be reproduced and distributed, without modification, for noncommercial purposes (e.g., use by healthcare providers in connection with their practices). Commercial use is defined as the sale, licensing, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial use of the Measures requires a license agreement between the user and NCQA. NCQA is not responsible for any use of the Measures. 

(c) 2008-2013 National Committee for Quality Assurance. All Rights Reserved. 

Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets.  NCQA disclaims all liability for use or accuracy of any CPT or other codes contained in the specifications.

CPT(R) contained in the Measure specifications is copyright 2004-2012 American Medical Association. LOINC(R) copyright 2004-2012 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2012 International Health Terminology Standards Development Organisation. ICD-10 copyright 2012 World Health Organization. All Rights Reserved.</copyright><disclaimer>These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.

THE MEASURES AND SPECIFICATIONS ARE PROVIDED ?AS IS? WITHOUT WARRANTY OF ANY KIND.

Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>Seniors receiving inappropriate medications are more likely to report poorer health status at follow-up, compared to seniors who receive appropriate medications (Fu, Liu, and Christensen 2004). In 2005, rates of potentially inappropriate medication use in the elderly were as large or larger than in a 1996 national sample, highlighting the need for progress in this area (Simon et al. 2005). While some adverse drug events are not preventable, studies estimate that between 30 and 80 percent of adverse drug events in the elderly are preventable (MacKinnon and Hepler 2003).

Reducing the number of inappropriate prescriptions can lead to improved patient safety and significant cost savings.  Conservative estimates of extra costs due to potentially inappropriate medications in the elderly average $7.2 billion a year (Fu, Liu, and Christensen 2004). Medication use by older adults will likely increase further as the U.S. population ages, new drugs are developed, and new therapeutic and preventive uses for medications are discovered (Rothberg et al. 2008). By the year 2030, nearly one in five U.S. residents is expected to be aged 65 years or older; this age group is projected to more than double in number from 38.7 million in 2008 to more than 88.5 million in 2050.  Likewise, the population aged 85 years or older is expected to increase almost four-fold, from 5.4 million to 19 million between 2008 and 2050.  As the elderly population continues to grow, the number of older adults who present with multiple medical conditions for which several medications are prescribed continues to increase, resulting in polypharmacy (Gray and Gardner 2009).</rationale><recommendations>The measure is based on the literature and key clinical expert consensus processes by Beers in 1997, Zahn in 2001 and an updated process by Fick in 2003, which identified drugs of concern in the elderly based on various high-risk criteria. NCQA's Medication Management expert panel selected a subset of drugs that should be used with caution in the elderly for inclusion in the proposed measure based upon these two lists.  NCQA analyzed the prevalence of drugs prescribed according to the Beers and Zhan classifications and determined that drugs identified by Zhan that are classified as never or rarely appropriate would form the basis for the list (Fick 2003).


Certain medications (MacKinnon 2003) are associated with increased risk of harms from drug side-effects and drug toxicity and pose a concern for patient safety. There is clinical consensus that these drugs pose increased risks in the elderly (Kaufman 2005). Studies link prescription drug use by the elderly with adverse drug events that contribute to hospitalization, increased length of hospital stay, increased duration of illness, nursing home placement and falls and fractures that are further associated with physical, functional and social decline in the elderly (AHRQ 2009).</recommendations><improvementNotations>Lower score indicates better quality</improvementNotations><references><reference>Zhan, C, et al. Potentially inappropriate medication use in the community-dwelling elderly. JAMA 2001; 286(22):2823-2868.</reference><reference>Beers, M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997; 157:1531-1536.</reference><reference>Fick, DM, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163:2716-2724.</reference><reference>Fu, A.Z., G.G. Liu, and D.B. Christensen. 2004. ?Inappropriate Medication Use and Health Outcomes in the Elderly.? J Am Geriatr Soc 52(11): 1934-9.</reference><reference>Gray, C.L, and C. Gardner. 2009. ?Adverse Drug Events in the Elderly: An Ongoing Problem.? J Manag Care Pharm 15(7):568-71.</reference><reference>AHRQ, National Quality Measures Clearinghouse. www.qualitymeasures.ahrq.gov (Accessed Web page: October 12, 2009).</reference><reference>MacKinnon, N.J. and C.D. Hepler. 2003. ?Indicators of Preventable Drug-related Morbidity in Older Adults: Use Within a Managed Care Organization.? J Managed Care Pharm 9:134-41.</reference><reference>Simon, S.R., K.A. Chan, S.B. Soumerai, A.K. Wagner, S.E. Andrade, A.C. Feldstein, J.E. Lafata, R.L. Davis, J.H. Gurwitz. 2005 ?Potentially Inappropriate Medication Use by Elderly Persons in U.S. Health Maintenance Organizations, 2000-2001.? J Am Geriatr Soc 53(2): 227-232.</reference><reference>Kaufman MB, et al. Effect of Prescriber Education on the Use of Medications Contraindicated in Older Adults in a Managed Medicare Population. J Manag Care Pharm 2005 April/May; 11(3):211-219.</reference><reference>Rothberg, M.B., P.S. Perkow, F. Liu, B. Korc-Grodzicki, M.J. Brennan, S. Bellantonio, M. Heelon, P.K. Lindenauer. 2008. ?Potentially Inappropriate Medication Use in Hospitalized Elders.? J Hosp Med 3:91-102.</reference></references><definitions>A high-risk medication is identified by either of the following:
     a.	 A prescription for medications classified as high risk at any dose and for any duration
     b. Prescriptions for medications classified as high risk at any dose with greater than a 90 day supply</definitions><guidance>The intent of Numerator 1 of the measure is to assess if the patient has been prescribed one high-risk medication.  The intent of Numerator 2 of the measure is to assess if the patient has been prescribed at least two different high-risk medications.

CUMULATIVE MEDICATION DURATION is an individual?s total number of medication days over a specific period; the period counts multiple prescriptions with gaps in between, but does not count the gaps during which a medication was not dispensed.
 
To determine the cumulative medication duration, determine first the number of the Medication Days for each prescription in the period: the number of doses divided by the dose frequency per day. Then add the Medication Days for each prescription without counting any days between the prescriptions.

For example, there is an original prescription for 30 days with 2 refills for thirty days each. After a gap of 3 months, the medication was prescribed again for 60 days with 1 refill for 60 days. The cumulative medication duration is (30 x 3) + (60 x 2) = 210 days over the 10 month period.</guidance><transmissionFormat>TBD</transmissionFormat><initialPatientPopDescription>Patients 66 years and older who had a visit during the measurement period</initialPatientPopDescription><denominatorDescription>Equals initial patient population</denominatorDescription><denominatorExclusionsDescription>None</denominatorExclusionsDescription><numeratorDescription>Numerator 1: Patients with an order for at least one high-risk medication during the measurement period. 
Numerator 2: Patients with an order for at least two different high-risk medications during the measurement period.</numeratorDescription><numeratorExclusionsDescription>Not applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>None</denominatorExceptionsDescription><measurePopulationDescription>Not applicable</measurePopulationDescription><measureObservationsDescription>Not applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="b803d356-c76d-42be-93fc-717e4c1a49b3">None</qualityMeasureSet>
<finalizedDate value="201404241343-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3d61-56a7-013e-65c9c31d3e55" name="ONC Administrative Sex"/><elementRef id="40280381-3d61-56a7-013e-65c9c31d3e56" name="Race"/><elementRef id="40280381-3d61-56a7-013e-65c9c31d3e57" name="Ethnicity"/><elementRef id="40280381-3d61-56a7-013e-65c9c31d3e58" name="Payer"/></supplementalDataElements><measureGrouping><group sequence="1"><clause displayName="Initial Patient Population 1" type="initialPatientPopulation" uuid="856330FA-2C33-47BF-9B35-3934D58FBFA2"><logicalOp displayName="AND" type="and"><relationalOp displayName="&gt;= 66 years Starts Before Start Of" operatorType="Greater Than or Equal To" quantity="66" type="SBS" unit="years"><elementRef displayName="birth date : Patient Characteristic Birthdate" id="40280381-3d61-56a7-013e-65c9c31d3e59" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-65c9c31d3e5a" type="qdm"/></relationalOp><relationalOp displayName="During" type="DURING"><logicalOp displayName="OR" type="or"><elementRef displayName="Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e5c" type="qdm"/><elementRef displayName="Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e5d" type="qdm"/><elementRef displayName="Preventive Care Services - Established Office Visit, 18 and Up : Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e5e" type="qdm"/><elementRef displayName="Preventive Care Services-Initial Office Visit, 18 and Up : Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e5f" type="qdm"/><elementRef displayName="Annual Wellness Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e60" type="qdm"/><elementRef displayName="Home Healthcare Services : Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e61" type="qdm"/></logicalOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-65c9c31d3e5a" type="qdm"/></relationalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="890A2C6E-4EDA-4122-B37A-25C2D0C0676E"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Numerator 1" type="numerator" uuid="5F0E3FD8-D025-4B57-AB23-7164930AF467"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><relationalOp displayName="During" type="DURING"><elementRef displayName="High Risk Medications for the Elderly : Medication, Order" id="40280381-3d61-56a7-013e-65c9c31d3e62" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-65c9c31d3e5a" type="qdm"/></relationalOp><relationalOp displayName="During" type="DURING"><elementRef displayName="High-Risk Medications With Days Supply Criteria : Medication, Order" id="40280381-3d61-56a7-013e-65c9c31d3e63" type="qdm"><attribute comparisonValue="90" mode="Greater Than" name="cumulative medication duration" unit="days"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-65c9c31d3e5a" type="qdm"/></relationalOp></logicalOp></logicalOp></clause><clause displayName="Numerator 2" type="numerator" uuid="1A051238-76A7-46EB-B240-8735EF7DE486"><logicalOp displayName="AND" type="and"><functionalOp displayName="COUNT &gt;= 2  " operatorType="Greater Than or Equal To" quantity="2" type="COUNT" unit=" " uuid="024d2e2c-9f5d-4805-aa65-e4d13964d21f"><logicalOp displayName="OR" type="or"><relationalOp displayName="During" type="DURING"><elementRef displayName="High Risk Medications for the Elderly : Medication, Order" id="40280381-3d61-56a7-013e-65c9c31d3e62" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-65c9c31d3e5a" type="qdm"/></relationalOp><relationalOp displayName="During" type="DURING"><elementRef displayName="High-Risk Medications With Days Supply Criteria : Medication, Order" id="40280381-3d61-56a7-013e-65c9c31d3e63" type="qdm"><attribute comparisonValue="90" mode="Greater Than" name="cumulative medication duration" unit="days"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-65c9c31d3e5a" type="qdm"/></relationalOp></logicalOp></functionalOp></logicalOp></clause></group></measureGrouping><elementLookUp><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3d61-56a7-013e-65c9c31d3e55" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="Administrative Sex" uuid="40280381-3d61-56a7-013e-65c9c31d3e55" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3d61-56a7-013e-65c9c31d3e56" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDC" uuid="40280381-3d61-56a7-013e-65c9c31d3e56" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3d61-56a7-013e-65c9c31d3e57" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDC" uuid="40280381-3d61-56a7-013e-65c9c31d3e57" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3d61-56a7-013e-65c9c31d3e58" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="Source of Payment Typology" uuid="40280381-3d61-56a7-013e-65c9c31d3e58" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Patient Characteristic Birthdate" id="40280381-3d61-56a7-013e-65c9c31d3e59" name="birth date" oid="2.16.840.1.113883.3.560.100.4" suppDataElement="false" taxonomy="LOINC" uuid="40280381-3d61-56a7-013e-65c9c31d3e59" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3d61-56a7-013e-65c9c31d3e5a" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3d61-56a7-013e-65c9c31d3e5a" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e5c" name="Office Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-65c9c31d3e5c" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e5d" name="Face-to-Face Interaction" oid="2.16.840.1.113883.3.464.1003.101.12.1048" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-65c9c31d3e5d" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e5e" name="Preventive Care Services - Established Office Visit, 18 and Up" oid="2.16.840.1.113883.3.464.1003.101.12.1025" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-65c9c31d3e5e" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e5f" name="Preventive Care Services-Initial Office Visit, 18 and Up" oid="2.16.840.1.113883.3.464.1003.101.12.1023" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-65c9c31d3e5f" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e60" name="Annual Wellness Visit" oid="2.16.840.1.113883.3.526.3.1240" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-65c9c31d3e60" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-65c9c31d3e61" name="Home Healthcare Services" oid="2.16.840.1.113883.3.464.1003.101.12.1016" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-65c9c31d3e61" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="40280381-3d61-56a7-013e-65c9c31d3e62" name="High Risk Medications for the Elderly" oid="2.16.840.1.113883.3.464.1003.196.12.1253" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-65c9c31d3e62" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="40280381-3d61-56a7-013e-65c9c31d3e63" name="High-Risk Medications With Days Supply Criteria" oid="2.16.840.1.113883.3.464.1003.196.12.1254" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-65c9c31d3e63" version="1"/></elementLookUp><strata displayName="Stratification"><clause displayName="Stratum 1" type="stratum" uuid="40280381-3d61-56a7-013e-65c9d4ab3e92"><logicalOp displayName="AND" type="and"/></clause></strata></measure>
